4//SEC Filing
Robbins Andrew R 4
Accession 0000899243-23-005135
CIK 0001622229other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 3:49 PM ET
Size
9.6 KB
Accession
0000899243-23-005135
Insider Transaction Report
Form 4
Robbins Andrews R
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2023-02-13+525,000→ 525,000 totalExercise: $13.63Exp: 2033-02-13→ Common Stock (525,000 underlying)
Footnotes (1)
- [F1]This stock option shall vest in equal monthly installments over a four year period.
Issuer
Cogent Biosciences, Inc.
CIK 0001622229
Entity typeother
Related Parties
1- filerCIK 0001590157
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 3:49 PM ET
- Size
- 9.6 KB